Helius Medical Technologies Inc has been issued two medical method patents (U.S. Patent Nos. 5,597,501 and 5,597,504) that, together, protect the intellectual property rights for its Portable Neuromodulation Stimulator (PoNS) device.
Altogether, Helius has been issued or has allowed 40 US and international patents covering the medical method, design, and device features associated with the PoNS device therapy.
The PoNS device is designed to deliver neurostimulation through the tongue. PoNS Therapy is used with physical or cognitive therapy, and is currently being evaluated via a multicenter clinical trial for the treatment of balance disorder in patients with mild to moderate traumatic brain injury, according to a media release from Newtown, Pa-headquartered Helius Medical Technologies Inc.
“Further strengthening our intellectual property with these two new medical method patents is a very meaningful development for the company,” says Philippe Deschamps, CEO of Helius Medical Technologies Inc, in the release.
[Source(s): Helius Medical Technologies Inc, Business Wire]
